GeneTether Addresses Mailing Delays Amid Postal Strike
GeneTether Advances Cancer Treatment and Leadership
GeneTether Therapeutics Inc: MDA EN
GeneTether Therapeutics Inc: AUDITED ANNUAL FINANCIAL STATEMENTS EN
GeneTether Therapeutics Inc. Announces Third Quarter 2023 Financial Results
GeneTether Therapeutics Board Provides Shareholder Update
GeneTether Therapeutics Inc: INTERIM MDA EN
GeneTether Therapeutics Inc: INTERIM FINANCIAL STATEMENTSREPORT EN
GeneTether Therapeutics Inc. Announces Second Quarter 2023 Financial Results
GeneTether Therapeutics Inc: INTERIM FINANCIAL STATEMENTS/REPORT - ENGLISH
GeneTether Therapeutics Inc: MD&A - ENGLISH
GeneTether Therapeutics Inc: AUDITED ANNUAL FINANCIAL STATEMENTS - ENGLISH
GeneTether Therapeutics Inc: AB FORM 13-501F2 (CLASS 2 REPORTING ISSUERS - PARTICIPATION FEE)
No Data